“What have you done for me lately, Lou?”
That’s a common refrain I hear from readers of my FREE newsletters. I get it. Readers are always looking for more great recommendations for free.
And candidly, I can’t blame them. In a world full of noise and pretenders, being skeptical about buying premium research makes sense.
So before you plunk down your hard-earned money for any paid recommendations, you want your “investment guru” to prove his or her worth with some free winning picks.
Why do I bring this up today? Simple. Because I’ve got some more free picks to give you!
But also because I have two questions for you — namely:
Will you act on this information I’m giving you?
And more importantly, will it be enough?
You’ve Got to be in It to Win It
Last week, I hosted an hour-long Portfolio Review & Future Technology Outlook webinar for subscribers of my premium research advisory, Micro-Cap Advantage.
During the subscriber-only event, I shared the Top 3 sectors to target for maximum gains in the next few months.
The first sector shouldn’t come as a surprise to you — it’s biotech.
As you know, after first predicting it would be a top-performing sector all the way back in April, I’ve been writing about biotech in this column for weeks now.
(In case you pulled a Rip Van Winkle and missed my research about why biotech is a red-hot investment opportunity — right now, and for the foreseeable future — you can catch up quickly here and here.)
And here’s one more piece of data to add to the overwhelmingly bullish set-up into year-end and 2021:
As Bruce Booth of Life Sci VC writes, “We’ve witnessed a tsunami of funding flows into the [biotech] sector. While other sectors have also experienced the exuberance of market appreciation, biotech’s buoyancy has exceeded most others.”
Indeed! And it’s continuing, particularly in the public markets.
Case in point: Biotech companies have accounted for 20% of all the money raised this year from IPOs and follow-on offerings, and 40% of the overall deals. In other words, the majority of funding rounds getting done right now are for biotech companies.
Put simply, the smart money is piling into biotech at a quickening pace. And as I’ve shared before, being a profitable trend trader means following big money flows, no matter where they’re going.
A clearer “buy” signal in the market simply doesn’t exist right now.
So — will you act on it?
Three (Free) Ways to Play the Biotech Boom
I ask because, if you’ve been paying close attention to Trend Trader Daily, you know that I’ve already shared two ways in previous columns to safely play this trend:
The Principal Healthcare Innovators Index ETF (BTEC) and the SPDR S&P Biotech ETF (XBI).
Both are up a solid 6% in just the two weeks since I recommended them, with plenty more room to run.
Of course, I don’t just give away free information and picks in this column…
I also do it during my live presentations!
For example, if you tuned into my event last week (the one where I told you in advance that I’d be sharing “the safest biotech stock to own today”), you’d be sitting on a 10% gain and counting.
And again, that’s in just one week’s time.
I’ve shared plenty of opportunities outside of biotech, too.
For example, if you’d tuned into my October 21st “Back to Your Financial Future” event, you’d have been given free research that included the name, ticker symbol, and specific buying instructions for a tech company at the epicenter of the $188 billion anti-counterfeiting market.
And if you acted on that free information, you’d now be sitting on profits of 61% and counting!
The list of my free recommendations for you goes on and on. For example:
- 10 days ago, I told you to short Zoom Video Communications, Inc. (ZM) ahead of its quarterly report. Pull up the ticker today. It’s down about 17.5%. In a single day.
- A few weeks before that, I told you to scoop up shares of LAM Research Corp. (LRCX), based on the uptick in semiconductor equipment sales. And that stock is up almost 50% already.
Did you act on any of these trades? I truly hope so!
And if so, at what point will I earn enough of your confidence to earn your business?
Only you know that answer.
But I can tell you this: my premium readers are enjoying significantly higher profits than my free readers.
For example, on average, my picks for my premium biotech service have soared more than 300% this year.
And many of my picks for my premium micro-cap service are already up by triple-digits and counting.
If you’re one of my premium readers, thank you for your vote of confidence.
But if you’re still on the fence, what are you waiting for?
Join Me Tonight
Later tonight, I’m hosting my last LIVE event of the year…
And guess what?
During this special online Zoom, I’ll be sharing a biotech investment opportunity, for free.
To get all the info you need to make this trade, you simply need to register for my event, and attend live.
To register before it’s too late, click here now »
And before the week is out, I plan to reveal two more trends for maximum gains heading into year-end.
Will that be enough?
For the sake of my business — and for the sake of your profits — I truly and sincerely hope so!
Ahead of the tape,
Lou Basenese
Source: http://www.crowdability.com/article/my-top-3-trends-heading-into-year-end
